Gijs Overheul, Pascal Miesen and Ronald van Rij, dept. of Medical Microbiology, theme Infectious diseases and global health, have elucidated the mechanism by which a DNA virus evades small RNA-based immunity of the host. They have published their results in PNAS.
Host immunity exerts strong selection pressure on viruses, often leading to the evolution of viral mechanisms to evade or suppress the immune response. It is well established that RNA interference (RNAi) is a potent antiviral immune system against RNA viruses. As a counter-defense, RNA viruses often encode proteins that suppress the RNAi response. RNAi also targets DNA viruses, but the antiviral effects seem to be modest.
Using the fruit fly Drosophila melanogaster and a large DNA virus of insects (IIV6) as model system, the research group of Van Rij, including former PhD candidates Walter Bronkhorst and Rob Vogels, has studied the complex interactions between virus and host RNAi. The researchers now show that wildtype IIV6 is indeed mostly insensitive to RNAi, but that an IIV6 mutant lacking its RNAi antagonistic protein becomes extremely sensitive to RNAi. Thus, RNAi is in fact strongly antiviral against DNA viruses, but virus-encoded immune antagonists can fully mask this antiviral activity.
On the photo, from left to right: Ronald van Rij, Gijs Overheul, Pascal Miesen
Related news items
'Stofwisselkracht' grant for Paola de Haas and Alessandra Cambi5 December 2019
Paola de Haas and Alessandra Cambi, theme Nanomedicine, have recently been awarded a grant from ‘Stichting Stofwisselkracht’ for their project entitled “Identification of immune-related symptoms in Congenital Disorders of Glycosylation”.read more
Newly appointed Principal Clinicians RIHS 2020 - 20225 December 2019
These caregivers are at the forefront of renewing patient care and take the lead in the development and realization of the Radboud vision.read more
Newly appointed Junior Principal Clinicians3 December 2019
The appointed junior Principal Clinician for RIMLS are Heidi Zweers-van Essen and Jenneke Leentjens. These caregivers are at the forefront of renewing patient care and take the lead in the development and realization of the Radboudumc vision.read more
Large research grant for Radboudumc Health Academy & HAN3 December 2019
The Radboudumc Health Academy and the HAN receive a large research grant of 875.000 euro from the NRO (Nationaal Regieorgaan voor Onderwijsonderzoek) on developing flexible expertise.read more
Exploration meeting Academic Alliance on Oncology2 December 2019
Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology.read more